diabetes

Open Access
How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?
Joshua J. Neumiller and Rita R. Kalyani

CJASN October 2019, CJN.05340419; DOI: https://doi.org/10.2215/CJN.05340419

Add to Selected Citations
Open Access
Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
Sadayoshi Ito, Tomoya Kagawa, Takuya Saiki, Kohei Shimizu, Shingo Kuroda, Yuhei Sano and Yuusuke Umeda

CJASN March 2019, 14 (3) 354-363; DOI: https://doi.org/10.2215/CJN.07720618

Add to Selected Citations
You have accessRestricted Access
End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy
Joy Chieh-Yu Chen, Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely, Robert C. Albright, Macaulay Onuigbo, Suzanne M. Norby, Christy L. Gossett, Margaret M. D’Uscio, Amy W. Williams, John J. Dillon and LaTonya J. Hickson

CJASN August 2018, 13 (8) 1172-1179; DOI: https://doi.org/10.2215/CJN.00590118

Add to Selected Citations
You have accessRestricted Access
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes
Claire Gerber, Xuan Cai, Jungwha Lee, Timothy Craven, Julia Scialla, Nao Souma, Anand Srivastava, Rupal Mehta, Amanda Paluch, Alexander Hodakowski, Rebecca Frazier, Mercedes R. Carnethon, Myles Selig Wolf and Tamara Isakova

CJASN June 2018, 13 (6) 884-892; DOI: https://doi.org/10.2215/CJN.11871017

Add to Selected Citations
You have accessRestricted Access
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD
Elaine Ku, Kirsten L. Johansen and Charles E. McCulloch

CJASN May 2018, 13 (5) 693-701; DOI: https://doi.org/10.2215/CJN.10360917

Add to Selected Citations
Open Access
Effects of Diabetes Medications Targeting the Incretin System on the Kidney
Richard J. MacIsaac and Merlin C. Thomas

CJASN February 2018, 13 (2) 321-323; DOI: https://doi.org/10.2215/CJN.10380917

Add to Selected Citations
You have accessRestricted Access
Burden of Proof—When Is Kidney Disease Attributable to Diabetes?
Pierre-Jean Saulnier and Robert G. Nelson

CJASN December 2017, 12 (12) 1917-1918; DOI: https://doi.org/10.2215/CJN.10720917

Add to Selected Citations
You have accessRestricted Access
Diabetes and CKD in the United States Population, 2009–2014
Leila R. Zelnick, Noel S. Weiss, Bryan R. Kestenbaum, Cassianne Robinson-Cohen, Patrick J. Heagerty, Katherine Tuttle, Yoshio N. Hall, Irl B. Hirsch and Ian H. de Boer

CJASN December 2017, 12 (12) 1984-1990; DOI: https://doi.org/10.2215/CJN.03700417

Add to Selected Citations
You have accessRestricted Access
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD
Meghan E. Sise, Elke Backman, Guillermo A. Ortiz, Gregory L. Hundemer, Nneka N. Ufere, Donald F. Chute, Joseph Brancale, Dihua Xu, Jessica Wisocky, Ming V. Lin, Arthur Y. Kim, Ravi Thadhani and Raymond T. Chung

CJASN October 2017, 12 (10) 1615-1623; DOI: https://doi.org/10.2215/CJN.02510317

Add to Selected Citations
You have accessRestricted Access
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis
Christiane Drechsler, Salim S. Hayek, Changli Wei, Sanja Sever, Bernd Genser, Vera Krane, Andreas Meinitzer, Winfried März, Christoph Wanner and Jochen Reiser

CJASN August 2017, 12 (8) 1265-1273; DOI: https://doi.org/10.2215/CJN.10881016

Add to Selected Citations

Main menu

User menu

Search

diabetes

Pages

About

Author Information

More information